Pradžia › Hemofilija › Pennsylvania
Hemofilija klinikiniai tyrimai Pennsylvania
6 tyrimai dėl Hemofilija ieško dalyvių vietose Pennsylvania.
Miestai Pennsylvania
Oficialus tyrimo tekstas (anglų kalba)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia
- The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia
Renkami dalyviai3 fazė
Amžius 18 ir vyresni · Vyrams · Atnaujinta 2026-10-02 · NCT05568719A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Penn State MS Hershey Med Ctr, Hershey
- St Christopher Hosp for Child, Philadelphia
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 64 · Vyrams · Atnaujinta 2026-09-18 · NCT07220564ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Hospital of Philadelphia, Philadelphia
- Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, Philadelphia
- St. Christopher's Hospital for Children, Philadelphia
- ir dar 1
Renkami dalyviaiStebimasis tyrimas
Visi amžiai · Visoms lytims · Atnaujinta 2026-08-17 · NCT04398628A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- Penn State Milton S Hershey Medical Center Pediatrics, Hershey
- Perelman Center for Advanced Medicine (PCAM)- Penn Blood Disorders Program, Philadelphia
Renkami dalyviai1 fazėLaukiami sveiki savanoriai
Amžius nuo 18 iki 60 · Visoms lytims · Atnaujinta 2026-07-02 · NCT06349473Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- The Feinstein Institutes for Medical Research, Philadelphia
Renkami dalyviai3 fazė
Amžius nuo 1 iki 74 · Vyrams · Atnaujinta 2026-07-01 · NCT05145127Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- Penn State College of Medicine, Hershey
Renkami dalyviai1 fazė
Amžius nuo 0 iki 90 · Visoms lytims · Atnaujinta 2026-04-03 · NCT05500807Iš ClinicalTrials.gov, duomenys gauti 2026-10-05. Kiekvienas tyrimas nustato savo tinkamumo kriterijus; tyrimo komanda sprendžia, kas gali dalyvauti.